David Piwnica‐Worms

26.0k citations

282 papers · 19.5k indexed · 4 hit papers · h-index 71

Oncology top 0.2%
- Drug Transport and Resistance Mechanisms 30
Cancer Research top 0.5%
Immunology top 0.5%
- Immunotherapy and Immune Responses 15
Molecular Biology top 0.5%
- bioluminescence and chemiluminescence research 24
- RNA Interference and Gene Delivery 19
Radiology, Nuclear Medicine and Imaging top 0.2%
- Radiopharmaceutical Chemistry and Applications 32
Genetics
- Virus-based gene therapy research 22
Biotechnology
- Cancer Research and Treatments 13
Pediatrics, Perinatology and Child Health
- Pharmacological Effects and Toxicity Studies 12

Co-authors: Julie L. Prior Seth T. Gammon James F. Kronauge Mark L. Chiu Gary D. Luker Shimon Gross Vijay Sharma Helen Piwnica‐Worms
Cited by: Oncology Cancer Research Immunology
Journals: Nature (1 paper)Chemical Reviews (1 paper)Proceedings of the National Academy of Sciences (14 papers)
Partner nations: United States Ireland Italy

In The Last Decade

David Piwnica‐Worms

279 papers receiving 19.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by David Piwnica‐Worms

Since Specialization

Citations

This map shows the geographic impact of David Piwnica‐Worms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Piwnica‐Worms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Piwnica‐Worms more than expected).

Fields of papers citing papers by David Piwnica‐Worms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Piwnica‐Worms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Piwnica‐Worms. The network helps show where David Piwnica‐Worms may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Piwnica‐Worms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Piwnica‐Worms Line = papers co-authored together David Piwnica‐Worms links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Hyperpolarized [1- ¹³ C]pyruvate-to-[1- ¹³ C]lactate conversion is rate-limited by monocarboxylate transporter-1 in the plasma membrane Proceedings of the National Academy of Sciences ·Yi Rao,Seth T. Gammon,Niki M. Zacharias,Tracy Liu,Travis C. Salzillo,Yuanxin Xi,Jing Wang,Pratip K. Bhattacharya,David Piwnica‐Worms	2020	50
2	Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS binders Proceedings of the National Academy of Sciences ·Yao-Cheng Li,Nikki K. Lytle,Seth T. Gammon,Luke Wang,Tikvah K. Hayes,Margie N. Sutton,Robert C. Bast,Channing J. Der,David Piwnica‐Worms,Frank McCormick,Geoffrey M. Wahl	2020	12
3	Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia Molecular Cancer Therapeutics ·Niki M. Zacharias,Natalia Baran,Sriram S. Shanmugavelandy,Jae-Hyuk Lee,Juliana Vélez Luján,Prasanta Dutta,Steven W. Millward,Tianyu Cai,Christopher G. Wood,David Piwnica‐Worms,Marina Konopleva,Pratip K. Bhattacharya	2019	22
4	Nucleoside Diphosphate Kinase-3 ( NME3 ) Enhances TLR5-Induced NF κ B Activation Molecular Cancer Research ·Kelly Flentie,Caleb González,Brandon Kocher,Yue Wang,Hongtu Zhu,Jayne Marasa,David Piwnica‐Worms	2018	17
5	A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models Clinical Cancer Research ·Pascal O. Zinn,Sanjay K. Singh,Aikaterini Kotrotsou,Islam Hassan,Ginu Thomas,Markus M. Luedi,Ahmed Elakkad,Nabil Elshafeey,Tagwa Idris,Jennifer Mosley,Joy Gumin,Gregory N. Fuller,John de Groot,Veera Baladandayuthapani,Erik P. Sulman,Ashok J. Kumar,Raymond Sawaya,Frederick F. Lang,David Piwnica‐Worms,Rivka R. Colen	2018	80
6	DAPK3 Suppresses Acini Morphogenesis and Is Required for Mouse Development Molecular Cancer Research ·Brandon Kocher,Lynn S. White,David Piwnica‐Worms	2014	10
7	A High-Throughput Fluorimetric Assay for 2-Hydroxyglutarate Identifies Zaprinast as a Glutaminase Inhibitor Cancer Discovery ·Adnan Elhammali,Joseph E. Ippolito,Lynne Collins,Jan R. Crowley,Jayne Marasa,David Piwnica‐Worms	2014	66
8	A Bioluminescent Transposon Reporter-Trap Identifies Tumor-Specific Microenvironment-Induced Promoters in Salmonella for Conditional Bacterial-Based Tumor Therapy Cancer Discovery ·Kelly Flentie,Brandon Kocher,Seth T. Gammon,Deborah V. Novack,Jeffrey S. McKinney,David Piwnica‐Worms	2012	67
9	Antagonism of Inhibitor of Apoptosis Proteins Increases Bone Metastasis via Unexpected Osteoclast Activation Cancer Discovery ·Chang Yang,Jennifer L. Davis,Rong Zeng,Paras Vora,Xinming Su,Lynne Collins,Suwanna Vangveravong,Robert H. Mach,David Piwnica‐Worms,Katherine N. Weilbaecher,Roberta Faccio,Deborah V. Novack	2012	34
10	Hedgehog Signaling Inhibition Blocks Growth of Resistant Tumors through Effects on Tumor Microenvironment Cancer Research ·Emanuela Heller,Michelle A. Hurchla,Jingyu Xiang,Xinming Su,Sara Chen,Jochen G. Schneider,Kyu-Sang Joeng,Marcos Vidal,Leah Goldberg,Hongju Deng,Mary C. Hornick,Julie L. Prior,David Piwnica‐Worms,Fanxin Long,Ross Cagan,Katherine N. Weilbaecher	2011	66
11	A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth Cancer Research ·David Y. Chen,Yishan Lee,Brian A. Van Tine,Adam C. Searleman,Todd D. Westergard,Han Liu,Ho-Chou Tu,Shugaku Takeda,Yiyu Dong,David Piwnica‐Worms,Kyoung Joon Oh,Stanley J. Korsmeyer,Ann Hermone,Richard Gussio,Robert H. Shoemaker,Emily H. Cheng,James J. Hsieh	2011	35
12	Suppression of G-protein–Coupled Receptor Kinase 3 Expression Is a Feature of Classical GBM That Is Required for Maximal Growth Molecular Cancer Research ·B. Mark Woerner,Jingqin Luo,Kristin R. Brown,Erin Jackson,Sonika Dahiya,Paul S. Mischel,Jeffrey Benovic,David Piwnica‐Worms,Joshua B. Rubin	2011	33
13	Cyclic AMP Suppression Is Sufficient to Induce Gliomagenesis in a Mouse Model of Neurofibromatosis-1 Cancer Research ·Nicole M. Warrington,Scott M. Gianino,Erin Jackson,Patricia Goldhoff,Joel R. Garbow,David Piwnica‐Worms,David H. Gutmann,Joshua B. Rubin	2010	87
14	The Neurofibromatosis Type 1 Tumor Suppressor Controls Cell Growth by Regulating Signal Transducer and Activator of Transcription-3 Activity In vitro and In vivo Cancer Research ·Sutapa Banerjee,Jonathan N. Byrd,Scott M. Gianino,Scott E. Harpstrite,Fausto J. Rodríguez,Robert G. Tuskan,Karlyne M. Reilly,David Piwnica‐Worms,David H. Gutmann	2010	49
15	CD47 Regulates Bone Mass and Tumor Metastasis to Bone Cancer Research ·Özge Uluçkan,Stephanie N. Becker,Hongju Deng,Wei Zou,Julie L. Prior,David Piwnica‐Worms,William A. Frazier,Katherine N. Weilbaecher	2009	67
16	Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant β-Catenin Activation in Colon Cancer Clinical Cancer Research ·Snehal Naik,Robin S. Dothager,Jayne Marasa,Cory L. Lewis,David Piwnica‐Worms	2009	58
17	Interleukin 12 Stimulates IFN-γ–Mediated Inhibition of Tumor-Induced Regulatory T-Cell Proliferation and Enhances Tumor Clearance Cancer Research ·Xuefang Cao,Karen Leonard,Lynne Collins,Sheng F. Cai,Joshua C. Mayer,Jacqueline E. Payton,Michael Walter,David Piwnica‐Worms,Robert D. Schreiber,Timothy J. Ley	2009	70
18	Senescent Stromal-Derived Osteopontin Promotes Preneoplastic Cell Growth Cancer Research ·Ermira Pazolli,Xianmin Luo,Sarah Brehm,Kelly Carbery,Jun-Jae Chung,Julie L. Prior,Jason M. Doherty,Shadmehr Demehri,Lorena Salavaggione,David Piwnica‐Worms,Sheila A. Stewart	2009	122
19	Blocking CXCR4-Mediated Cyclic AMP Suppression Inhibits Brain Tumor Growth In vivo Cancer Research ·Lihua Yang,Erin Jackson,B. Mark Woerner,Arie Perry,David Piwnica‐Worms,Joshua B. Rubin	2007	115
20	Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers Proceedings of the National Academy of Sciences ·Joseph E. Ippolito,Matthew E. Merritt,Fredrik Bäckhed,Krista L. Moulder,Steven Mennerick,Jill K. Manchester,Seth T. Gammon,David Piwnica‐Worms,Jeffrey I. Gordon	2006	33

About David Piwnica‐Worms

David Piwnica‐Worms is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Biophysics, having authored 282 papers that have together received 19.5k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (32 papers), Drug Transport and Resistance Mechanisms (30 papers), bioluminescence and chemiluminescence research (24 papers), Virus-based gene therapy research (22 papers), RNA Interference and Gene Delivery (19 papers), Immunotherapy and Immune Responses (15 papers), Cancer Research and Treatments (13 papers) and Pharmacological Effects and Toxicity Studies (12 papers). The work is most often cited by research in Oncology (5.8k citations), Cancer Research (2.7k citations) and Immunology (3.3k citations). David Piwnica‐Worms has collaborated with scholars based in United States, Ireland and Italy. Frequent co-authors include Julie L. Prior, Seth T. Gammon, James F. Kronauge, Mark L. Chiu, Gary D. Luker, Shimon Gross, Vijay Sharma, Helen Piwnica‐Worms, Lynne Collins and Joel R. Garbow. Their work appears in journals such as Nature, Chemical Reviews and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact